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RESEARCH
Self monitoring of blood glucose in type 2 diabetes:
longitudinal qualitative study of patients’ perspectives
Elizabeth Peel, lecturer in psychology,1 Margaret Douglas, consultant in public health medicine,2
Julia Lawton senior research fellow3
ABSTRACT
Objective To explore views of patients with
type 2 diabetes about self monitoring of blood
glucose over time.
Design Longitudinal, qualitative study.
Setting Primary and secondary care settings across
Lothian, Scotland.
Participants 18 patients with type 2 diabetes.
Main outcome measures Results from repeat in-depth
interviews with patients over four years after clinical
diagnosis.
Results Analysis revealed three main themes—the role of
health professionals, interpreting readings andmanaging
high values, and the ongoing role of blood glucose self
monitoring. Self monitoring decreased over time, and
health professionals’ behaviour seemed crucial in this:
participants interpreted doctors’ focus on levels of
haemoglobin A1c, and lack of perceived interest in meter
readings, as indicating that self monitoring was not worth
continuing. Some participants saw readings as a proxy
measure of good and bad behaviour—with women
especially, chastising themselves when readings were
high. Some participants continued to find readings
difficult to interpret, with uncertainty about how to
respond to high readings. Reassurance and habit were
key reasons for continuing. There was little indication that
participants were using self monitoring to effect and
maintain behaviour change.
Conclusions Clinical uncertainty about the efficacy and
role of blood glucose self monitoring in patients with type
2 diabetes is mirrored in patients’ own accounts. Patients
tended not to act on their self monitoring results, in part
because of a lack of education about the appropriate
response to readings. Health professionals should be
explicit about whether and when such patients should
self monitor and how they should interpret and act upon
the results, especially high readings.
INTRODUCTION
Effective self management is considered the corner-
stone of successful diabetic control, and self monitor-
ing of blood glucose may have a role in this. For type 2
diabetes, however, there is still no firm agreement
among diabetes health professionals1-3 and in the
research literature4-9 about the role and value of self
monitoring.
Despite the lack of conclusive evidence of an
association between self monitoring of blood glucose
and glycaemic control (even in large scale
observational studies with heterogeneous groups of
patients10-12) and findings that self monitoring may
lead to anxiety,13 clinical practice guidelines often
promote self monitoring by patients with type 2
diabetes. They stress that it “canbeuseful in preventing
hypoglycaemia and adjusting medications, medical
nutritional therapy, and physical activity.”14 They
often refer to research that supports self monitoring:
for example, the Canadian Diabetes Association15
cites one of the few observational studies16 that showed
it was associated with lower concentrations of haemo-
globin A1c in diabetic patients not treated with insulin.
The UK National Institute for Clinical Excellence
(NICE) contended that “self monitoring should be
taught if the need/purpose is clear and agreed with
the patient. Self monitoring can be used in conjunction
with appropriate therapy as part of integrated self-
care.”17 Thus the recommendation to self monitor
appears in guidance to doctors, although its clinical
benefit remains inconclusive.18
We assessed the views of patients with newly diag-
nosed diabetes about self monitoring of blood glucose,
since they are responsible for taking and responding to
readings on a daily basis, and found that they held
positive and negative views.19 Positive aspects were
that, in the absence of symptoms or complications,
self monitoring provided patients with evidence that
they had diabetes, and low readings offered reassur-
ance and promoted a sense of “success.” Although
self monitoring could increase awareness of the impact
of diet on blood glucose levels, it also created a sense of
failure if readings remained high. High readings that
were counterintuitive posed particular problems for
patients and could lead to abandonment of dietary
regimens. These findings suggested that patients with
well controlled diabetes viewed self monitoring
positively, but patients with poorly controlled diabetes
were likely to voice concerns. Our research also
identified early signs of “monitoring fatigue” in these
patients.
As our study was restricted to patients with newly
diagnosed diabetes, we undertook a follow-up study
to gain a longitudinal perspective of the patients’
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views and use of blood glucose self monitoring. Our
aims were to explore patients’ experiences and views
of self monitoring over time, responses to high or low
readings, reasons for increasing or decreasing self
monitoring, and views of the advice and feedback
received from health professionals. This analysis
forms part of a broader study examining the views of
patientswith type 2 diabetes about health service deliv-
ery and their experiences of managing their
disease.20-25
METHOD
In 2002-3, we recruited 40 patients who had received a
clinical diagnosis of type 2 diabeteswithin the previous
six months and interviewed them three times over the
following year. The sample was selected to reflect the
demographic spread of people with type 2 diabetes in
Lothian and Scotland and to include patients receiving
diabetes care in hospital and in general practice. The
recruitment strategy is discussed in detail elsewhere.26
We obtained ethical approval to keep participants’
contact details for re-contact later if they gave written
consent. Of the 21members of the original cohort who
consented, we interviewed 20 three years later in 2006
(one had died in the interim). There were no obvious
differences between this subgroup and the original
cohort in terms of demographic characteristics or
their earlier views about selfmonitoring.The table pro-
vides demographic information for this subgroup.
This paper reports findings from the 18 participants
who had ever self monitored their blood glucose. We
coded all the data pertaining to self monitoring of
blood glucose for these participants across their four
interviews and examined these data looking at
whether, and forwhat reasons, the participants’ experi-
ences of and views about self monitoring had changed
over the four years.We undertook a thematic analysis,
which involved repeatedly reading the extracts and
then organising them into categories. Themes were
compared between members of the analysis team
until consensus was reached.27 Data are tagged with
participants’ sex, identifying number, and interview
round (for example, M37.4 refers to the fourth (final)
interview of male participant 37).
RESULTS
Seven of the participants were self monitoring blood
glucose at the start of data collection, rising to 16 at
the end of the first year. At the fourth interview, three
Demographic details of patientswith type 2 diabetes (n=20)
No of patients
Age (years)*:
40-49 5
50-59 1
60-69 11
≥70 years 3
Sex:
Women 9
Men 11
Socioeconomic status†:
I-II 6
III non-manual 5
III manual 8
IV-V 1
Treatment at initial interview (2002-3):
Diet only 9
Tablets (monotherapy) 11
Tablets (combination therapy) 0
Insulin and tablets 0
Treatment at final interview (2006):
Diet only 6
Tablets (monotherapy) 5‡
Tablets (combination therapy) 8
Insulin and tablets 1
*Mean age at final interview 60.8 years (range 40-80).
†Using registrar general’s classification system.
‡Three participants reported a dose increase.
Box 1 | The role of health professionals onparticipants’ views of blood glucose self
monitoring
Participant F8.4:
Q: So did they ever ask to see your readings that you’d taken?
A: Oh no, no. I don’t even think they’ve asked me if I’ve got a meter.
Q: So they’ve not shown much interest in that really?
A: Well I suppose they only go on their own.
Q: So, like we talked a bit about how you’d use the blood glucose meter and what are
you doing at the minute in terms of that, have you stopped doing it completely?
A: Yes, stopped totally because, whereas I thought I was doing quite well, and when he
[diabetologist] said to me I wasn’t, I thought, “Well that’s pointless using that machine.”
Maybe lulling myself into a false sense of security.
Participant M1.4—They seem to place emphasis on the Hb [glycated haemoglobin], the
three monthly reading. Erm, that was always the—an issue that I could never quite work
out at the start. They would—the doctors would be more concerned about the three
monthly reading, because that’s what your average is, eh, and that didn’t take account
of my concerns, which were the big spikes I was getting. Erm, but any chat I have with
the doctors nowadays, it tends to be on the, the three monthly reading and not the kind
of meter readings that I have. So I guess that’s maybe the evidence that they are
content with for me to kind of manage and deal with the readings on a day to day basis I
assume.
Participant F9.4—When he [diabetologist] said was I testing my blood and I’m saying,
“Yes,” y’know, “I do it twice a week, Tuesday and Saturday, before breakfast and two
hours after my evening meal.” And I just kind of got the feeling, y’know, nothing—no
look on his face or anything—I just kind of got the feeling that was a bit much for a
diabetic that’s down here, y’know, when he’s dealing with ones away up here, y’know.
Erm, and I’m very diligent. I’ve kept a diary all—for all these years I kept a note of it.
Participant M17.4:
Q: I’m just interested in terms of why you kind of—y’know, at what point you decided
not to do that anymore. Was it something that kind of dropped off, or were you told by
health professionals that it wasn’t something?
A: No, no I wasn’t. But I did gather the impression that they didn’t really bother too
much with the day to day results . . . they certainly didn’t, sort of, ask for these. In fact,
when I did—if I told them about it they were inclined to say, “Oh it varies very much
depending on whether you’ve had a cup of tea or a biscuit or whatever,” y’know. At
least, I got that impression, Liz, and it seemed to me that it—it maybe wasn’t worth
keeping an eye on all of this.
Participant F33.4—Why did I stop? Because it was sore and I didn’t like it. And then I
kept thinking, “Well I’m filling out this book, nobody ever looks at it.” And you go to the
doctors, and they take your blood, and they can decide from what your levels are—so
why am I inflicting this pain on myself for nothing?
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years later, 10 were still regularly self monitoring. Of
these, three were self monitoring twice a day two times
a week (as recommended during their initial diabetes
education), five were checking at least weekly or
fortnightly, and one was checking three times every
other day. Another participant had started taking
insulin, and checked blood glucose levels at least two
or three times daily. Of the eight who were not
regularly self monitoring, one did so “once in a blue
moon” (participant F14.4), and one did so once a
month. One participant had lost his glucose meter
three weeks before the interview, and the remaining
five had stopped completely. Therefore, in our sample,
fewer people were self monitoring at the end of the
follow-up study, and, among those who still were, self
monitoring was undertaken less frequently.
Three main themes emerged from our analysis: the
role of health professionals; interpreting readings and
managing high values; and the ongoing role of, and
participants’ relationship with, self monitoring.
The role of health professionals
Participants emphasised the impact that their relation-
ships with general practitioners, diabetes nurses, and
diabetologists had on their self monitoring (box 1).
Participants were often provided with glucose meters
in primary or secondary care settings and received
initial education about how to use them. Some who
had purchased their own meter reported receiving
instructions from a nurse in general practice.19
None of the participants reported having been
explicitly told by health professionals to stop self
monitoring, nor had they received additional
education about self monitoring after the first year
following diagnosis. Most, however, voiced concerns
about the value that health professionals placed on
their readings by their fourth interview. Participants
who had had contact with diabetologists had “got the
feeling” (participant F9.4) “that they didn’t really
bother too much with the day-to-day results” (partici-
pant M17.4). Another participant commented that
“there seems to be in the health service various ideas
where you take it every day, you take it two times a
week, or people are not bothered if you take the two
month or the three month back check through your
blood” (participant M37.3).
Over time, participants had gained the impression
that glycated haemoglobin (HbA1c) was the more
reliable measure of glucose control on which health
professionals based treatment decisions (see partici-
pant M1.4 in box 1). This led to some participants
regarding self monitoring as less important as time
went on, or even “pointless” (participant F8.4).
How participants viewed healthcare professionals
sometimes seemed to affect their attitude to self
monitoring. In our sample, older and less well
educated participants articulated being particularly
interested in what they perceived to be health
professionals’ attitudes and had, for example, stopped
self monitoring because “nobody ever looks at it”
(participant F33.4). Others in these groups did not
engage with their readings, but simply collected data
on their readings in the hope that their doctor would
take an interest (“four checks in the week, I do. But
I write it down, and that’s as far as it goes” participant
M35.4).
Self monitoring is suggested to facilitate patient
empowerment,14 but it was evident from these partici-
pants’ accounts that they were self monitoring for their
health professionals’ benefit, rather than for their own,
even though the professionals did not show interest in
the readings.
Interpreting readings and managing high values
Interpreting readings remained problematic for some
participants (box 2), as did counterintuitive readings
(such as participant F8.4 in box 3).19 Four years after
diagnosis, for some, self monitoring of blood glucose
“was just a number” (participant F33.4). In part, this
was because no participants reported receiving
ongoing education about it. Although low readings
presented no problem to participants, as they knew
Box 2 | Interpreting readings andmanaging high values fromblood glucose self
monitoring
Participant F15.4:
Q: And what do you think when it’s higher than normal, y’know, higher than the,
sort of, 6s?
A: I always says, “I should be dead” (laughs). That’s what I usually say. If it’s awfae
[awfully] high I says, “Well I shouldnae be here.” But I don’t—that’s what I dinnae
understand either. I says, “What do you do when it’s high?” She [diabetes specialist
nurse] never explained that. I’ve asked Lyn [neighbour with type 1 diabetes] that, but
she disnae ken [know] either—when you can get it up, but how do you get it down
again.
Q: And nobody’s really . . . ?
A: Nope. Nobody seems to—I don’t suppose there’s nothing you could do.
Participant F33.4:
Q: When you were doing them was there anything you found useful about doing it?
A: I don’t think so. I mean it was just a number which really didn’t make an awful lot of
sense to me. And it should be between this and this, so if you were below that or you
were above it, I can understand if you’ve got to sort of regulate all your. Like one of the
girls at work; she’s on insulin, so they take hers so that they can regulate her food
intake and things. If it comes to that, then you have to do it because it’s one of these
things you have to do. But at the moment it’s not. I mean it doesn’t seem to have any
impact on what I’m doing daily anyway.
Participant M35.3—When you monitor it, it’s supposed to be between 4 and 8. What I
don’t understand is when it jumps up. I know if it goes low, you eat something to bring it
up. What if it goes high, what do you do to bring it down?
Participant F14.3—[In response to a high reading] I really watch what I eat. But there’s a
time in the day I get—I can’t go for ages without something to eat. I have to have a wee
snack or something.
Participant F36.4:
Q: So what are they like at the minute?
A: Fine, like 6-7, 8 even. But when it went up, it was 14-16, and I thought, “What do I
do?” y’know.
Q: Yeah, yes . . . were you having those readings for—consistently for a period of time—
those 14-16?
A: Not con . . . not every—quite often. And then I thought, “I’ll need to go to the doctor
and see.” And that’s when he put me on the metformin.
Participant M19.4—It had obviously crept up from when I started taking readings. But it
got to a point where I felt, y’know, it was high both in themorning and in the evening. So
that’s when I took it up with the doctor.
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that eating would raise their blood glucose levels, they
reported struggling to know what to do in response to
high readings—ranging from puzzlement (participant
M35.3) to great anxiety, as they thought high values
signalled that they “should be dead” (participant
F15.4).
If participants did implement a lifestyle change in
response to high readings, this tended to be an instant
solution rather than a permanent alteration such as
long term adjustments to diet. For example, one
woman commented that she temporarily stopped
eating in response to high readings (participant
F14.3). For some participants, the self monitoring
technology seemed to promote a focus on the “here
and now,” which could be detrimental to long term
health behaviours and decision making. Overall,
participants gave little indication that they were using
self monitoring to guide ongoing change to their life-
styles. Only three participants were prompted by
higher readings to seek medical advice, which led to
their medication being altered (such as participant
M19.4). These participants were well educated men
who indicated that they took an active role in
consultations.
The ongoing role of self monitoring
Healthcare providers’ lack of interest in their readings
was the reason some gave for discontinuing self
monitoring (see box 1). Moreover, the ways in which
participants made either internal or external
attributions for their blood glucose readings affected
their attitudes to self monitoring (box 3). Ironically,
most participants who had reduced or stopped self
monitoring were those who made internal attributions
(such as their food consumption) and blamed them-
selves for high readings. From a biomedical perspec-
tive, blood glucose readings are used to gain a picture
of fluctuation in blood glucose levels to help under-
stand about overall glycaemic control; however,
many participants viewed and interpreted readings as
a proxy measure of short term good or bad behaviour.
As one participant (M25.1) said, “I must be doing all
right when I get a low reading.” This focus on
individual behaviour often centred around diet and
eating practices28 rather than other aspects of diabetes
management, such as exercise or medication.
Participants did not tend to attribute high readings to
progression of the disease.
This association between self monitoring and
individual behaviour was particularly marked for
women and was closely aligned with a language of
self chastisement. Women talked about avoiding self
monitoring when they were eating inappropriately
(such as participant F14.2 in box 3) or, conversely,
taking a reading to prove their guilt about inappropri-
ate eating (such as participant F16.4).Men, on the other
hand,weremore inclined to use a discourse of curiosity
(such as participant M37.4), and more sanguinely
attribute high readings to external causes such as
their medication (“You get the odd sudden blip—like
Box 3 | Ongoing role of blood glucose selfmonitoring
Reasons for discontinuing
Self chastisement
Participant F8.4:
A: I must admit if I was having, eh, an indulgence like a Chinese or something I never
bother checking it (laughs) ’cos I knew it would be high.
Q: Were there any times where you checked blood sugar levels and thought, “I don’t
know why I’m getting this figure?”
A: Yes. Oh aye, quite a lot. Yes, but then I thought, “Well I’ve no medical knowledge so.”
But sometimes I did think, “That’s a bit unfair, I’ve been really good,” y’know.
Q: So it would be higher than you would be maybe expecting it to be?
A: Exactly. And I must admit I do find—well say, for instance, I’ve had my breakfast in
the morning and I’ve had a busy day, so I’ve maybe not had anything to eat ’till about
tea time. If I do it before it’s quite low, ’cos obviously I’ve not eaten anything.
So I suppose it is all down to what you eat, eh.
Participant F14.2—It’s telling me I’m being bad maybe or not keeping—not being strict
enough—and I think, “Oh oh, I ain’t using you today,” or whatever. I think that’s why I
don’t use it.
Participant F16.4:
A: Some mornings it would be great, other mornings it would be awful. Sometimes at
lunch times it was (sigh); you’d think, “What have I had? Oh I had a digestive biscuit,
maybe that was it.” But they say you can eat a digestive biscuit, y’know. So you bla—try
to think, “What on earth’s caused it?” y’know.
Q: Yeah and were you about to say you blame yourself?
A: Yeah, yeah.
Q: Which is never—
A: It’s not, no, y’know. You think, “Well I’ve not done that so it shouldnae be high,”
y’know. And then if you have eaten something and you are high you thought, “Well hell
bloody mend you, you shouldnae have eaten that,” y’know.
Bodily awareness
Participant F14.4—I’m controlling this myself. I dinnae need a machine to tell me that
it’s low, high, middle, what’s wrong . . . I ken when it’s gonnae be high, and I ken when
it’s mediocre, and I know when it’s low.
Participant M25.4—I normally, I know how I feel—whether sort of high or low, eh, and if
I feel OK and take my medication, eh, I dinnae bother taking my blood.
Consistency in readings
Participant M23.4—It wasn’t varying to any degree, and I stopped it really within a
couple of months . . . I thought, “Well what’s the point?” when I’m not getting any
readings that are in any way a cause for concern.
Participant M28.4—I stopped about a year ago because I was getting to the stage
I was getting the same sort of levels every day . . . it wasn’t sort of fluctuating up
and down.
Reasons for continuing
Curiosity
Participant M37.4—My average when I do my morning and evening checks is
around what I need, y’know, 7s. I don’t know what it is now, I’ll just have a quick
check for you.
Participant M1.4—I got a big slab [of cake]. I thought, “I’m going to monitor my blood
after this.” And I took it. Within about 40 minutes I was up to about [a] 22 blood sugar
reading. Now that was proof to me that—that I needed somethingmore than the tablets
I was taking.
Reassurance
Participant F39.4—At first Dr M thought that the meter thing might be a bit fiddly for me
and that, and I said, “Well I would rather have that so’s I know exactly what’s going on.”
And I do find it reassuring that when you do your check you can see right away what’s
registering and that.
Participant M1.4—[The meter is] there to kind of reassure me when I do sort of sense
that something—I don’t feel quite right. It’s there to kind of give me the—reassure me
it’s not a hypo’ coming on. That’s the main thing.
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one day I forgot to take the tablet at the right time,”
participant M19.3).
Other reasons for reducing or stopping self monitor-
ing were participants’ increased awareness of their
bodily signs and symptoms (one woman used itchy
skin as an indicator of high blood glucose) and having
faith in their subjective knowledge of their blood
glucose, and consistency in readings. Two participants
reported getting stable, predictable readings and so
were not gaining any new information.
Reassurance was a key reason for continuing self
monitoring, and for some it seemed to have become
integrated into their self image (“It’s part of me now,”
participant F9.4) or merely routine behaviour (“Just a
habit,” participant F36.4).
DISCUSSION
In our sample of people with type 2 diabetes, partici-
pants attenuated self monitoring of blood glucose over
time for various reasons, including health
professionals’ perceived disinterest in their results.
Consistent, stable readings and increased awareness
of physical indicators of hyperglycaemia were also
reasons for discontinuing. Participants who attributed
their results to external causes (such as lack of
medication) weremore likely to continue self monitor-
ing than those (typically women) who blamed their
own behaviour for high readings. Reassurance and
habit were key reasons for continuing self monitoring.
Interpreting readings and knowing how to act on high
readings remained problematic, and there was little
indication that participants were using self monitoring
to guide or maintain behaviour change. This may help
explain why studies find no association between self
monitoring and glycaemic control.
Our findings suggest that the clinical uncertainty
about the benefit of self monitoring of blood glucose
in patients with type 2 diabetes is reflected in patients’
own views about it. Our results support previous
research that has indicated that patients taking oral
treatment tend not to take action based on their blood
glucose readings,29 but our study also suggests reasons
for this. The role of health professionals is crucial,
particularly as patients seem to need more guidance
about interpreting and responding to readings
(see box 4).30 If patients cannot understand their
blood glucose fluctuations they cannot modify their
behaviour. How to act on high readings was a
consistent problem. Some participants had (appropri-
ately) attenuated self monitoring because their read-
ings were stable;1 some had stopped self monitoring
because they had inferred that health professionals
did not consider it important. Others continued with-
out engaging with the results. In all cases, participants’
accounts showed a lack of an explicit and unified
message from their healthcare team about if, when,
and how they should be self monitoring. Some practi-
tioner guidelines advise asking for patients’ inter-
pretations of their readings,31 and this study has
highlighted that patients need explicit education and
dialogue about whether to continue self monitoring
and how to respond to readings.
Attempts to find a concrete association between self
monitoring of blood glucose and glycaemic control in
patients with type 2 diabetes have investigated factors
such as age, sex, duration of diabetes, and frequency of
self monitoring.4-13 While our study lends some
support to the relevance of sex, age and social class, it
also signals that other factors may affect patients’
attitudes to self monitoring. A complex interplay of
both demographic and personality characteristics
may influence whether patients undertake self
monitoring and whether it has a positive impact on
glycaemic control. We found that different individuals
with similar results chose to continue or to stop self
monitoring on the basis of factors such as whether
they attributed readings to internal or external factors.
This suggests that education should be tailored to
patients’ beliefs and values. Further research in
homogeneous groups rather than heterogeneous
populations, which takes into account the subtle
interaction of personality and diabetes management
style (alongside more easily measured variables)
could be a fruitful avenue to pursue.
Although we studied patients’ perspectives about
blood glucose self monitoring, our results may apply
to patient administered health technologies more
generally. The strengths of this study are that it
includes both newly diagnosed and veteran patients’
views about self monitoring, provides an in-depth
longitudinal perspective, and addresses self monitor-
ing holistically within patients’ broader views about
their diabetes andhealth service provision.The study’s
weaknesses are that it relied on patients’ accounts, and
neither objective measures of glycaemic control nor
health professionals’ viewswere examined.We endea-
voured to select a sample that reflected the spread of
thepopulation of patientswithdiabetes inLothian, but,
Box 4 | Clinical recommendations
 Education about self monitoring of blood glucose
should be ongoing and tailored to patients’ individual
needs at any stage in their diabetes management
 Patients would benefit from clear, consistent signals
from the different health professionals whom they
consult about whether they should be self monitoring
and how they should be interpreting readings
 Clear goals should be negotiated and agreed with
patients
 During patient education, particular emphasis should
be placed on how patients should respond to high
readings, as well as low readings
 The relation between individual readings and patterns
in blood glucose results should be clarified with
patients
 The connections between HbA1c and self monitoring
of blood glucose should be made explicit, to enable
better understanding of the relation between, and
importance of, short, medium, and long term
glycaemic control
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as with all qualitative research, our findingsmay not be
generaliseable to other settings.
Future research could usefully explore healthcare
professionals’ attitudes toward self monitoring in this
group, examine the information32 and guidance being
provided to patients about it during consultations, and
focus on the particular characteristics/personalities of
patients that maymake self monitoring problematic or
beneficial for quality of life and glycaemic control.
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WHAT IS ALREADY KNOWN ON THIS TOPIC
There is no conclusive evidence for an association between self monitoring of blood glucose
and improved glycaemic control in patients with type 2 diabetes
Patients’ perspectives about self monitoring are largely absent from debates about the value
of the practice
WHAT THIS STUDY ADDS
Patients’ use of self monitoring decreases over time, informed by the perceived disinterest of
health professionals towards it
Patients find results difficult to interpret and act on, and few patients use self monitoring to
guide and maintain changes to their behaviour or lifestyle
Education about blood glucose self monitoring should be explicit, goal oriented, tailored to
individual needs, and on a continuous basis
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